FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Baxter Recalls Intralipid Lot Due to Subfreezing Storage

Baxter International recalls one shipment from a single lot of Intralipid 20% IV Fat Emulsion, 100 mL, after it was exposed to subfreezing temperature...

Human Drugs

Policy on Providing ANDA Review Status Updates to Sponsors

CDER publishes a new Manual of Policies and Procedures (MAPP 5200.12) on Communicating Abbreviated New Drug Application Review Status Updates with Ind...

Human Drugs

FDA Awards 15 Clinical Research Grants for Rare Diseases

FDA awards 15 new clinical trial research grants totaling more than $22 million to advance product development for patients with rare diseases.

FDA General

Gottlieb Says FDA Working Daily on Puerto Rico Manufacturing Capacity

FDA continues working with Puerto Rico-based manufacturing facilities to restore their capacity in order to prevent possible medical product shortages...

Biologics

2017 CBER Recalls Up From 2016

A FY 2017 CBER recall posting report details an 11% increase in total recalls over FY 2016.

Human Drugs

ACLU Suit Challenges Mifeprex REMS

The ACLU files suit against FDA REMS restrictions on access to the Mifeprex abortion pill.

Human Drugs

Court Says Eye Drop Dispenser Suit Preempted

Attorney JP Ellison says a Massachusetts federal court ruled that suits challenging dispensers for prescription eye drops were preempted because the m...

Human Drugs

Jonca Bull Leaves FDA Again for PPD Consulting

FDA Office of Minority Health director Jonca Bull leaves FDA to join Pharmaceutical Product Development in a dual role as head of regulatory consultin...

Human Drugs

Drug Compounder Charged with $10 Million Fraud

The Justice Department announces a plea agreement with an Alabama drug compounder charged with defrauding the Tricare military healthcare program out ...

Federal Register

FDA/Canada Joint Public Meeting on ICH Preparation

Federal Register notice: FDA announces a 10/19 regional public meeting entitled Health Canada and U.S. Food and Drug Administration Joint Public Consu...